Submission of Notice of EGM of the members of the Company to be held on 09th May, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited, BSE Scrip Code: 536565) has called an Extra-Ordinary General Meeting on Friday, May 9, 2025 at 3:30 PM through Video Conferencing. The EGM has two items of business: (1) confirming the appointment of Mr. Lakshman Samala (DIN: 10783725) as an Independent Director for a 5-year term effective February 12, 2025, passed as a Special Resolution; and (2) confirming the appointment of Mr. Jivamohan Divakar Valluri (DIN: 09218013) as a Non-Executive Non-Independent Director effective April 12, 2025, passed as an Ordinary Resolution. Mr. Samala is a Ph.D. in Organic Chemistry with over 25 years of experience in pharmaceutical packaging, while Mr. Valluri is a senior journalist with over 40 years of experience. E-voting will be conducted via CDSL from May 6 to May 8, 2025, with May 2, 2025 as the cut-off date.
Routine corporate governance matter with no direct financial or operational impact on shareholders. Shareholders should watch for the EGM outcome, as the appointments will formalize the board composition and may signal a shift in strategic direction for the company.